T3	Value 62 89	greater than or equal to 40
T4	Person 57 61	aged
T5	Value 94 124	less than or equal to 89 years
T7	Scope 62 124	greater than or equal to 40 and less than or equal to 89 years
R1	Has_scope Arg1:T4 Arg2:T7	
T8	Value 161 181	between 90g and 200g
T9	Measurement 147 160	prostate size
T10	Procedure 200 203	MRI
R3	Has_value Arg1:T9 Arg2:T8	
R4	AND Arg1:T9 Arg2:T10	
T11	Condition 229 264	lower urinary tract symptoms (LUTS)
T12	Temporal 269 312	at least 6 months prior to study enrollment
T13	Reference_point 296 312	study enrollment
R5	Has_index Arg1:T12 Arg2:T13	
R6	Has_temporal Arg1:T11 Arg2:T12	
T14	Measurement 329 339	IPSS score
T15	Value 343 354	at least 13
T16	Temporal 355 366	at baseline
T17	Reference_point 358 366	baseline
R7	Has_index Arg1:T16 Arg2:T17	
R8	Has_value Arg1:T14 Arg2:T15	
R9	Has_temporal Arg1:T14 Arg2:T16	
T18	Condition 387 418	refractory to medical treatment
T19	Condition 420 456	contraindicated to medical treatment
T20	Condition 461 486	refuses medical treatment
*	OR T18 T19 T20
T21	Condition 504 530	refuses surgical treatment
T22	Condition 537 575	contraindicated for surgical treatment
*	OR T21 T22
T23	Measurement 631 634	PSA
T24	Temporal 622 630	baseline
R10	Has_temporal Arg1:T23 Arg2:T24	
T25	Value 635 645	< 4.0ng/mL
R11	Has_value Arg1:T23 Arg2:T25	
T26	Measurement 688 691	PSA
T27	Temporal 679 687	baseline
R12	Has_temporal Arg1:T26 Arg2:T27	
T28	Value 692 703	>/= 4 ng/mL
T29	Measurement 719 734	prostate biopsy
T30	Value 710 718	negative
R13	Has_value Arg1:T29 Arg2:T30	
R14	Has_value Arg1:T26 Arg2:T28	
T31	Multiplier 736 746	minimum 12
T32	Procedure 747 758	core biopsy
R15	Has_multiplier Arg1:T32 Arg2:T31	
T33	Temporal 760 786	within the prior 12 months
T34	Scope 622 759	baseline PSA < 4.0ng/mL (no prostate biopsy required) OR baseline PSA >/= 4 ng/mL AND a negative prostate biopsy (minimum 12 core biopsy)
R16	Has_temporal Arg1:T34 Arg2:T33	
T35	Scope 679 733	baseline PSA >/= 4 ng/mL AND a negative prostate biops
*	OR T35 T23
T1	Observation 21 44	signed informed consent
